<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR38">
 <label>38.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Schuind</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Segall</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Drame</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Innis</surname>
    <given-names>BL</given-names>
   </name>
  </person-group>
  <article-title>Immunogenicity and safety of an EB66 cell-culture-derived influenza a/indonesia/5/2005(H5N1) AS03-adjuvanted vaccine: a phase 1 randomized trial</article-title>
  <source>J. Infect. Dis.</source>
  <year>2015</year>
  <volume>212</volume>
  <fpage>531</fpage>
  <lpage>541</lpage>
  <pub-id pub-id-type="doi">10.1093/infdis/jiv091</pub-id>
  <?supplied-pmid 25722291?>
  <pub-id pub-id-type="pmid">25722291</pub-id>
 </element-citation>
</ref>
